Browse by
  • |
  • |
  • |
  • |
  • |
  • |
  • |
  • |
  • |
  • |
  • |

A

Online Submissions

Already have a Username/Password? GO TO LOGIN

Need a Username/Password? GO TO REGISTRATION

Registration and login are required to submit items online and to check the status of current submissions.

 

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.

The submission has not been previously published, nor is it before another journal for consideration (or an explanation has been provided in Comments to the Editor).

The submission file is in Microsoft Word or RTF document file format.

The text adheres to the stylistic and bibliographic requirements outlined in the Guidelines for Authors, which is found in About the Journal.

B

Guidelines for Authors

  • 01 - Instructions to Authors
  • 02 - Types of Articles
  • 03 - Scholar Development Program


 

Instructions to Authors

Authors must follow the Uniform Requirements for Manuscripts (URM) and fulfill the Conflict of Interest mandates, as per the International Committee of Medical Journal Editors (ICMJE) Guidelines.

 

  • Copyright

    Submission of a manuscript implies:

    The article has not been published before nor is under consideration for publication (except in the form of an abstract, or as part of a published lecture, or thesis)

    When accepted for publication, the authors agree to automatic transfer of copyright to the publisher.

  • Review Process

    Every submission will be reviewed by expert reviewers. The editor-in-chief will have the final decision. Decisions will be made as rapidly as possible. The editorial board may re-review manuscripts that are accepted pending revision. JMI publishes manuscripts after the review process is completed.

  • Reporting Standards

    For studies dealing with diagnostic accuracy, please refer to the Standards for Reporting of Diagnostic Accuracy (STARD) checklist in the 2010 March issue of BMJ (Schulz, Altman, Moher, 2010)http://www.bmj.com/content/340/bmj.c332.

    For meta-analyses of randomized controlled trials, please refer to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) Statement.http://www.prisma-statement.org/

  • Text Formatting

    Manuscripts should be submitted as Office 2010 Microsoft Word (.docx or .doc) files, with double-spacing of all text with adequate margins. The following fonts may be used: Arial, Garamond, Calibri, Helvetica, Times, or Times New Roman, using 12 point fonts. To ensure anonymity during peer-review, authors' names should only appear on the title page.

  • Abbreviations

    Abbreviations should be used only when the full term is very long or is used often. The abbreviation should be spelled out and introduced in parentheses () the first time. Only recommended SI units should be used. Authors should use the solidus presentation (mg/ml).

  • Length

    Scientific articles should be no longer than 5,000 words with 40 references, 5 figures, and 5 tables. Review articles and invited commentary can be 10,000 words, 12 figures and/or Tables. Short Reports, Letters to the Editor, Book Reviews should be no more than 1000 words.

  • Structure of original scientific reports

    A structured abstract section of no more than 300 words, containing the following 4 subheadings: Background and Objectives, Methods, Results, Conclusion.

    The body of all original articles should be organized under the following headings: Introduction, Methods, Results, Discussion, and Acknowledgements.Conclusions should be stated in a couple of sentences at the end of the manuscript.

    If quotations from the Qur’an or Ahadith, it should be on a separate line in the text.It should be given a reference number in the text and listed in the reference section. See examples in theReferences section.

  • Introduction

    Provides a clear statement of the problem, the relevant literature on the subject, and the proposed approach or solution.

  • Methods

    Provides sufficient information to allow experiments to be reproduced. However, only truly new procedures should be described in detail; previously published procedures should be cited only with important modifications mentioned. Trade names should be capitalized and include the manufacturer's name and address. The radiological technique should be described in sufficient detail to be easily understood by general physicians.

  • Results

    Presents findings with clarity and precision. Findings from the authors' experiments should be described in the past tense, whereas previously published findings should be described in the present tense. Results should be explained without referring to the literature.

  • Discussion

    Interprets the findings in view of results obtained in the current and in past studies on the topic under discussion.

  • Conclusions

    Should be stated in no more than four sentences at the end of the paper.

  • Acknowledgements

    To acknowledge people, grants, funding, etc.

  • Tables

    Tables should be prepared in Microsoft Word/Excel, typed, double-spaced, and include headings and footnotes. Tables should be typed on a separate page, numbered consecutively, and have a heading and a legend. The same data should not be presented in tables, graphs or text.

  • Figure Legends

    Figure legends should be in a numerical order on a separate sheet. Graphics should be prepared using high-resolution GIF, TIFF, JPEG, or PowerPoint images before being inserted in the Microsoft Word file. Graphics must be grayscale with resolution greater than or equal to 300dpi. Designate figures as (Figure 1) and so on. Axes of graphs should be clearly labeled. Legends should begin with a title and include sufficient details to be understandable without referencing the text.

    When reporting experiments on human subjects, including in the Methods section that the study was approved by the authority on human experimentation of the institution in which the study was performed. Also, indicate that the procedures followed were in accord with the ethical standards of theHelsinki Declaration (JAMA, 1997;277:925-6). In the case of experimentation on animals, indicate in the Methods section that the NationalResearch Council’s guide for the care and use of laboratory animals was followed and that the approval of the local institution was obtained.

    Direct quotations, tables, or figures that have appeared in copyrighted material must be accompanied by written permission for their use from the copyright owner and original author along with complete reference information.

    Author(s) is/are responsible for all the statements made in his/their work, including changes made by the copy editor.

  • References

    References should be cited in the text by means of numbers in parentheses and be listed at the end of the manuscript in numerical order, in the order in which they appear in the text. Articles in preparation, articles submitted for publication, unpublished observations, personal communications, etc. are not included in the reference list but are mentioned in the text (e.g., “A. Kingori, University of Nairobi, Kenya, personal communication”). Journal names should be abbreviated without periods, and follow the style of the National Library of Medicinehttp://www.ncbi.nlm.nih.gov/nlmcatalog/journals. References should follow ICMJE Recommendationshttp://www.nlm.nih.gov/bsd/uniform_requirements.html (formerly the Uniform Requirements for Manuscripts). Some examples are listed below.

    Examples a. Standard journal article List the first six authors followed by et al. (Note: NLM now lists all authors.) Halpern SD, Ubel PA, Caplan AL. Solid-organ transplantation in HIV-infected patients. N Engl J Med. 2002;347:284-7.

    More than six authors:
    Rose ME, Huerbin MB, Melick J, Marion DW, Palmer AM, Schiding JK, et al. Regulation of interstitial excitatory amino acid concentrations after cortical contusion injury. Brain Res. 2002;935(1-2):40-6.

    Optional addition of a database's unique identifier for the citation: [Edited 12 May 2009] Halpern SD, Ubel PA, Caplan AL. Solid-organ transplantation in HIV-infected patients. N Engl J Med. 2002 Jul 25;347(4):284-7. PubMed PMID: 12140307.

    Forooghian F, Yeh S, Faia LJ, Nussenblatt RB. Uveitic foveal atrophy: clinical features and associations. Arch Ophthalmol. 2009 Feb;127(2):179-86. PubMed PMID: 19204236; PubMed Central PMCID: PMC2653214.

    Optional addition of a clinical trial registration number: [Added 12 May 2009] Trachtenberg F, Maserejian NN, Soncini JA, Hayes C, Tavares M. Does fluoride in composers prevent future caries in children? J Dent Res. 2009 Mar;88(3):276-9. PubMed PMID: 19329464. ClinicalTrials.gov registration number: NCT00065988.

    b. Organization as an author: Diabetes PreventionProgram Research Group. Hypertension, Insulin, and proinsulin in participants with impaired glucose tolerance. Hypertension.2002;40(5):679-86.

    c. No author given: 21st century heart solution may have a sting in the tail. BMJ.2002;325(7357):184.

    d. Personal author(s) of books and monographs: Murray PR, Rosenthal KS, Kobayashi GS,Pfaller MA. Medical microbiology. 4th ed. St.Louis: Mosby; 2002.

    e. Editor(s), compiler(s) as the author: Gilstrap LC3rd, Cunningham FG, VanDorsten JP, editors.Operative obstetrics. 2nd ed. New York: McGraw-Hill; 2002.

    f. Hadith from the database: Sahih Al-Bukhari, Book79, Kitaab al-Tibb, Chapter 1, Hadith 5354. [on-line] Available from: http://www.muhaddith.org.

Scholar Development Program

 

  • Introduction

    A great deal of worthy research conducted by scholars, particularly in the developing world remains unpublished due to inadequate mentorship, language difficulties, lack of data analysis skills, etc. The Journal of Medics International (JMI) has instituted a Scholar Development program to facilitate collaboration between emerging scholars and experienced researchers and faculty around the world. Provided all review standards are met, JMI will publish the resulting manuscript. These collaborations will lead to the publication of important research, illustrate worldwide differences in health and disease prevalence and management, provide much-needed capacity-building, and ultimately to unifying science and ethical understanding.

  • Process

    • 01 - (Associate Editor, JMI) will be responsible for this program.
    • 02 - The Scholar Development will fulfill the following criteria:
    • 03 - An emerging scholar will initiate the request for assistance.
    • 04 - A senior academician will be sought from IMI Academic Council to accept the request to assist.
    • 05 - An agreement will be signed by the Associate Editor, emerging scholar and senior academician where the scholar will remain the first author and the senior academician will be invited to be a co-author.
    • 06 - Once complete, the manuscript must be submitted to JMI for peer review.
    • 07 - Upon publication, the article shall be identified as the product of the Scholar Development program.
    • 08 - No fees of any kind shall be involved.
C

Copyright Notice

Authors who publish with this journal agree to the following terms:

Authors retain ownership of the copyright for their content. All content in Journal of Medics International, unless otherwise noted, is licensed under a Creative Commons Attribution—Non-Commercial—Share Alike License (https://creativecommons.org/licenses/by-nc-sa/3.0/us/). Under this license, authors' work may be downloaded, redistributed, and new creations built upon it for non-commercial purposes provided that the authors are credited and the derived work is licensed under identical terms. Authors are responsible for obtaining the rights to use 3rd party materials prior to submission.

Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.

Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)http://opcit.eprints.org/oacitation-biblio.html.

D

Privacy Statement

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.

E

Measuring Impact

The Journal Impact Factor http://wokinfo.com/essays/impact-factor/ derived by Thomson Reuters requires at least three complete years of publishing before issuing an Impact Factor for a journal. After fulfilling these criteria, JMI will be submitted for evaluation for an Impact Factor.

F

Abstracting and Indexing

JMI will be indexed in Google Scholar and will eventually be submitted for indexing to MEDLINE and the Directory of Open Access Journals.